$ABCL — FinTwit mentions on Surfaced

$ABCL — FinTwit mentions on Surfaced

Recent mentions

74 mentions

@tradableastroJul 7, 2026 · 2:38 PM

Name level, the index keeps finding them. $CRNX top of 1,257 scored names at a perfect 100. The 100 club already paying since added. $TENB +22%. $MRNA +15.7%. $ABCL +15.5%. $GLUE +13.1%. RS leaders from the scan: $AXON, $PANW, $CRL, $TECH leading. Laggards: $MPWR, $ORCL, $SMCI.

@investmentguru_Jul 4, 2026 · 10:34 PM

The Next Multi-Bagger Will Start as an Asymmetrical Bet $QS at $7 $SERV at $6.31 $JOBY at $8.49 $ONDS at $7.41 $SOUN at $6.55 $SATL at $5.43 $TE at $8.56 $SIVEF at $5.28 $OPEN at $4,90 $ABCL at $8.11 not a financial advice

@investmentguru_Jul 2, 2026 · 3:45 PM

Biotechnology stocks are doing better in this market $ABCL $RXRX

@investmentguru_Jul 1, 2026 · 11:38 PM

While AI continues to dominate headlines, Biotechnology is quietly becoming one of the strongest sectors in the market. Top 15 Biotechnology Stocks to Watch: $VRTX – Leader in cystic fibrosis treatments and expanding into gene-editing and rare diseases. $RVMD – Focused on precision oncology targeting RAS-driven cancers. $CRSP – Pioneer in gene-editing with approved and pipeline therapies. $NTLA – Developing in-vivo gene-editing treatments with breakthrough potential. $ABCL – AI-powered antibody discovery platform for drug development. $RXRX – Uses AI and automation to accelerate drug discovery at scale. $BEAM – Specializes in base-editing gene technology for precise DNA correction. $XENE – Focused on neurology and epilepsy-related treatments. $GH – Leader in liquid biopsy cancer diagnostics and early detection. $TWST – Produces synthetic DNA used in genomics and biotech research. $CGON – Developing immunotherapy treatments for bladder cancer and oncology. $DNLI – Focused on neurodegenerative diseases like Alzheimer’s and Parkinson’s. $IMVT – Developing therapies for autoimmune diseases using antibody technology. $ARWR – RNA interference platform targeting genetic and chronic diseases. $KRYS – Commercial-stage gene therapy company focused on rare skin disorders. These names represent the frontier of modern medicine where genetics, AI, and precision therapies are converging. As capital rotates beyond AI infrastructure, biotech is shaping up as one of the most compelling long-term opportunity sectors.

@investmentguru_Jun 29, 2026 · 11:16 AM

3 Biotech Companies on My Radar: $ABCL, $RXRX, $PRME

@investmentguru_Jun 24, 2026 · 4:18 PM

$ABCL 11% up today

@moninvestorJun 23, 2026 · 11:03 PM

These are my favourite stocks across the themes I believe have the strongest tailwinds over the next decade: Nuclear: $SMR Robotics: $OUST Rare Earth: $UAMY Copper: $COPX ETF Memory: $DRAM ETF Solar: $CSIQ, $TE & $ENPH Drones: $ONDS & $KRKNF (UUVs) Space: $SATL, $RKLB, $ASTS & $VELO Health/Bio: $HIMS, $IBRX, $ABCL & $PRME AI Infrastructure: $IREN, $NUAI, $NBIS & $KEEL *Not the full list. I've spent countless hours researching these sectors one by one, building positions only after developing strong conviction. Some ideas came from X, such as UAMY, but the majority were discovered through my own research long before they became widely discussed on X. Of all the names here, IREN, HIMS, and ONDS remain my highest-conviction positions this year (currently trading HIMS/ONDS). I currently see the most attractive combination of execution, market opportunity, and long-term upside for these 3 stocks. This list is a snapshot of where my research has led me today and the sectors I believe could benefit from some of the most powerful technological and industrial shifts taking place over the next decade. Because I run a concentrated portfolio, I can't own every stock I like. Every position has to earn its place. Currently own 8 stocks out of that list. NFA.

@investmentguru_Jun 17, 2026 · 12:50 AM

10 Risk/Reward Setups I’m Watching Right Now $QS $ABCL $HIVE $FABC $SOUN $SERV $JOBY $VLN $SATL $TE These aren’t necessarily the safest stocks in the market, but they offer some of the most interesting upside potential relative to current valuations if execution and market conditions cooperate. Not financial advice. Do your own research.

@investmentguru_Jun 15, 2026 · 10:31 AM

EARLY-STAGE COMPOUNDERS — ACCUMULATE NOW OR CHASE LATER $QS Solid-state battery tech, potential EV/energy storage game-changer Volkswagen partnership + scaling toward commercial production, multi-year payoff window $JOBY eVTOL air taxi pioneer, FAA certification progress advancing Toyota-backed, building toward commercial launch — first-mover in urban air mobility $SERV Sidewalk delivery robots, Uber/Nvidia-backed Scaling fleet across major US cities, early innings of autonomous last-mile delivery $SOUN Voice AI infrastructure across auto, restaurants, healthcare, enterprise Diversified revenue base, riding the conversational AI adoption wave $ABCL AI-driven antibody discovery platform Partnerships w/ major pharma, royalty-stream model on future drug approvals These are pre-mainstream-adoption names across disruptive themes — batteries, air mobility, robotics, voice AI, and AI-driven biotech. The pattern across every megatrend cycle is the same: early accumulation in unloved/volatile names vs. chasing once the narrative is obvious and priced in. High risk, high reward — position sizing matters. Not financial advice.

@investmentguru_Jun 1, 2026 · 10:59 AM

$ABCL https://t.co/SkhyhkZRG6

@investmentguru_Jun 1, 2026 · 1:41 AM

Fifteen setups. Different risk profiles, different timelines, different catalysts. $BB — BlackBerry pivoted hard into cybersecurity and automotive software (QNX). The embedded OS angle in autonomous vehicles is a long-duration call option most ignore. $SOUN — SoundHound is pure-play voice AI at a time when agentic interfaces are going mainstream. Volatile, but the revenue trajectory is improving. $MX — Magnachip Semiconductor sits at the intersection of OLED display drivers and power management. Korea-listed, under-followed, and levered to the display upgrade cycle. $BBAI — is a defense-facing AI analytics name. With DoD AI spending ramping and Golden Dome catalysts in play, this is a high-beta beneficiary. $HIVE — HIVE Digital has quietly built out GPU compute infrastructure alongside its crypto mining ops. Dual revenue streams make this more interesting than it appears on the surface. $KEEL — Keeler is a small-cap with an asymmetric setup. Low institutional coverage means price discovery happens fast when catalysts arrive. $QS — QuantumScape is the solid-state battery moonshot. Binary outcome risk is real, but if the technology delivers, the upside is generational. Volkswagen backing provides credibility. $JOBY — Joby Aviation is the leading eVTOL name heading into commercialization. FAA certification progress + Delta partnership makes this the cleanest air taxi risk/reward in the space. $VIVO — Meridian Bioscience rebranded, but the core diagnostics business is steady. Healthcare names with stable cash flow offer defensive exposure in volatile tape. $TE — T1 Energy is a clean energy infrastructure play at the early stage. If the AI power demand thesis plays out, names like this get re-rated quickly. $VLN — Valens Semiconductor is the connectivity layer inside automotive and machine vision systems. MIPI A-PHY adoption is the catalyst to watch. Deeply undervalued relative to the tech. $SPCE — Virgin Galactic remains highly speculative. The Delta class vehicle program is the make-or-break moment. Small position, eyes wide open. $ABCL — AbCellera is biotech infrastructure — the picks-and-shovels play on drug discovery. Pipeline royalty streams could compound quietly over time. $ONDS — Ondas Holdings gives you drone infrastructure + railway automation in one vehicle. The FirstNet/FAA drone corridor opportunity is significantly underpriced by the market. $SIVEF — Sivers Semiconductors is my highest-conviction name on this list. Swedish InP photonics + 5G chip manufacturer sitting at the exact bottleneck of the AI optical interconnect buildout. 400%+ already and still not on most radars. That’s where asymmetric reward lives. Not financial advice. DYOR.

@investmentguru_May 30, 2026 · 3:16 PM

Portfolio Update — May 30, 2026 $PLTR +842.76% $CLS +596.56% $ONDS +572.16% $NBIS +501.63% $RKLB +386.43% $IONQ +273.92% $HIMS +241.05% $RDW +228.77% $OKLO +188.78% $MU +172.90% $SOFI +169.69% $ABCL +118.25% $TSLA +92.57% $QS +81.77% $NVDA +78.89% $AAOI +74.60% $AMZN +50.53% $GLXY +43.15% $META +29.24% $RR +15.51% $PNG +15.53% $SOUN +14.29% $JOBY +11.59% $MBLY +2.28% Cash: ~4.5% of portfolio 24/24 positions green 💚🔥 Zero red positions — full green portfolio 🙌 Not financial advice. DYOR.

@investmentguru_May 29, 2026 · 7:53 PM

$ABCL https://t.co/tYfu0YoGA1

@investmentguru_May 25, 2026 · 3:22 PM

PORTFOLIO holdings UPDATE — May 2026 $PLTR — AI operating system with government + commercial compounding. The original conviction hold. $CLS — Advanced packaging demand accelerating. Every AI chip cycle runs through here. $ONDS — IoT connectivity thesis validated. Small-cap patience rewarded. $NBIS — Neocloud identity forming in Europe. GPU cloud + AI services stack underappreciated. $HIMS — Consumer health disruption intact. GLP-1 tailwinds + DTC model building durable margins. $OKLO — Microreactor backlog growing. AI data center power demand makes this the logical baseload answer. $RKLB — Launch cadence strong. SpaceX IPO catalyst hasn’t even landed yet. $SOFI — Neobank evolving into a full financial platform. The flywheel is strengthening. $IONQ — Trapped-ion architecture holds its edge. Volatility is the cost of entry on this one. $AAOI — 800G to 1.6T upgrade cycle is the thesis. Hyperscaler capex flows directly here. $ABCL — AI-driven drug discovery still undervalued vs pure-play AI names. $MU — HBM ramp for AI training is the re-rating catalyst. Cyclical + secular tailwinds aligned. $AMZN — AWS AI layer compounding quietly. Margin expansion underway. $QS — Solid-state battery timeline extending but the TAM remains massive. High conviction, high patience. $GLXY — Institutional crypto infrastructure play. Regulatory clarity improving. $RDW — Quiet beneficiary of in-space manufacturing. Government contracts provide the floor. $META — Ad machine funding a long-term AI moat. Execution consistently underestimated. $SOUN — Voice AI expanding into enterprise. Execution needs to match the narrative. $PATH — Enterprise budget pressure real. Monitoring AI-native competition closely. $JOBY — eVTOL certification is the gating factor. This is a 2027+ story. $TSLA — Robotaxi and FSD are the real thesis now. Energy storage remains overlooked. $RR — Richtech Robotics bringing AI-powered service automation to hospitality and food service. Robotics adoption cycle still early. $PNG — Kraken Robotics underwater technology and defence sonar thesis building. Watching for contract catalysts to confirm the move. This portfolio is built around long-duration themes: ⚡ AI Infrastructure ☁️ NeoCloud 🚀 Space Economy ⚛️ Quantum 🔋 Energy Transition 🤖 Robotics 🧬 AI Healthcare Volatility is noise. Execution + patience is the edge. Not financial advice.

@investmentguru_May 22, 2026 · 12:19 AM

Some of my small caps are moving nicely today with 5%+ gains $QS $RR $ABCL $SERV This is why patience and buying strong conviction names on weakness matters. Small caps can move fast once momentum returns.

@investmentguru_May 13, 2026 · 10:33 AM

15 stocks where I see early positioning opportunities across different sectors for long term growth: $QS $VLN $EOSE $SIVEF $JOBY $SATL $SOUN $SERV $BBAI $PLUG $ABCL $BB $FABC $RR $KRKNF This basket covers next generation batteries, energy storage, photonics, eVTOL, space, AI software, robotics, defense AI, hydrogen, cybersecurity and deep value turnaround plays. Not every stock will work immediately, and some may take years to fully play out, but that’s how asymmetric investing works. Early bets require patience, conviction and risk management. Big money is usually made by identifying future themes before they become crowded trades. For me, this is about building positions slowly, surviving volatility and giving disruptive sectors time to mature. Patience pays in the long term IMO.

@investmentguru_May 11, 2026 · 10:33 AM

$DGXX $SLNH $SATL $SIDU $LWLG $POET $BB $KEEL $KOPN $VLN $GCTS $SHMD $ASTI $BLNK $ABCL $SIVEF Some good-looking small cap and early-bet setups in this market right now. A mix of Space, photonics, AI infrastructure, biotech, energy, EV, and speculative tech names starting to show improving momentum and accumulation. Still a high-risk area of the market, so position sizing and patience matter, but selective small caps continue to outperform when momentum returns.

@investmentguru_May 9, 2026 · 1:55 PM

20 Stocks That Could Be the Next Market Leaders $JOBY — eVTOL pioneer. FAA cert in final stages. eIPP program launching mid-2026. Air taxi market is real and near. $QS — Solid-state battery game-changer. Eagle Line now operational. First ecosystem partner billings recorded. VW-backed. $900M+ cash runway through 2029. $SERV — Autonomous sidewalk delivery. Uber Eats + DoorDash partnerships. Physical AI playing out in real time. $SATL — Satellogic. Sub-meter satellite imagery. Defense, agriculture, intelligence. Geopolitical tailwinds are massive. $VLN — High-speed connectivity chips for automotive ADAS and camera systems. $SOUN — SoundHound AI. Voice AI before it’s mainstream. Automotive + hospitality deployments accelerating. $NOK — Nokia. 5G infrastructure + optical networking exposure. Massively undervalued relative to peers. $BB — BlackBerry. IoT security + government contracts. The silent cybersecurity play nobody’s watching. $POET — Optical interposer platform for AI data centers. POET’s platform could be the backbone of next-gen interconnects. $LWLG — Lightwave Logic. Electro-optic polymer tech hitting 400G+ speeds. Fortune 500 customer at Stage 3. IP licensing model unlocking. $OPEN — Opendoor. Real estate tech beaten down. Rate cut cycle = massive re-rating catalyst. $RUM — Rumble. Free speech platform with growing creator economy + cloud infrastructure. Political tailwinds turbocharging user growth. $ONDS — Ondas Holdings. Drones for defense + railroads. Government contracts stacking up quietly. $ABCL — AbCellera. AI-driven antibody discovery. Royalty model means high-margin revenue from partner pipelines. $RR — AI-powered service robots for hospitality, food & beverage, healthcare. $TMQ — Trilogy Metals. Copper + cobalt. Critical minerals for the AI/EV infrastructure buildout. $EOSE — Eos Energy. Iron-air long-duration batteries for grid storage. AI data centers need this. $SMR — NuScale Power. Only NRC-approved SMR design. DOE loans incoming. 6 GW pipeline across TVA territory. $TE — Advanced American solar and battery manufacturing $BBAI — AI analytics for defense and intelligence. DoD spending = durable revenue floor. These names span eVTOL, photonics, solid-state batteries, robotics, defense AI, energy, and beyond. Most are early. All carry risk. But the ones that execute? They don’t just go up — they redefine their sectors. Not financial advice.

@investmentguru_May 7, 2026 · 12:15 AM

Great day for this small cap $QS $SOUN $JOBY $BB $SERV $OSS $ABCL $DGXX $SATL $SMR

@investmentguru_May 6, 2026 · 10:43 AM

In this market, you have two choices: Chase overextended names after the move… or build positions early in stocks still in the accumulation phase. I’d rather accumulate where risk/reward is still favorable: $QS $SOUN $JOBY $BB $SERV $CIFR $PATH $ABCL $NOK $SATL $SMR The biggest money is usually made by getting in before the crowd notices — not after the breakout headlines.

@investmentguru_May 2, 2026 · 12:53 PM

Portfolio Update — May 2, 2026 $PLTR +770.82% $CLS +651.53% $ONDS +426.29% $NBIS +307.04% $HIMS +258.82% $OKLO +202.32% $RKLB +170.77% $SOFI +142.97% $IONQ +142.02% $AAOI +104.43% $TSLA +73.50% $ABCL +55.79% $MU +52.72% $AMZN +48.89% $QS +48.22% $GLXY +37.05% $RDW +27.67% $META +24.47% $SOUN +20.76% $PNG +15.68% $RR -3.13% $PATH -4.04% $JOBY -13.05% 20/23 green 3 positions in progress — conviction intact $SOUN officially in the green Cash: 8.6% of portfolio 🙌 Not financial advice.

@investmentguru_May 1, 2026 · 10:52 AM

In 10 months 8/10 gave big returns $AEHR +841% $ASTS +270% $RKLB +267% $OUST +200% $INDI +105% $AQST +94% $QS +79% $ABCL +66% $SOUN -19% ❌ $PCVX -16% ❌

@investmentguru_Apr 25, 2026 · 12:03 PM

Portfolio Update — April 25, 2026 $PLTR +758.70% $CLS +642.59% $ONDS +443.81% $HIMS +298.95% $NBIS +283.43% $OKLO +206.23% $SOFI +173.08% $RKLB +172.65% $IONQ +126.51% $AAOI +80.27% $NVDA +75.20% $TSLA +66.38% $ABCL +47.72% $AMZN +47.02% $QS +46.40% $MU +39.84% $META +38.04% $RDW +33.56% $GLXY +27.42% $PNG +25.00% $SOUN +1.23% new position $RR -5.06% 🩸 $PATH -7.09% 🩸 $JOBY -19.70% 🩸 Cash: 8.7% of portfolio 21/24 green. 3 positions in progress — conviction intact. $GLXY & $SOUN flipped green. 🙌 Not financial advice. DYOR.

@investmentguru_Apr 18, 2026 · 10:35 PM

$ABCL AbCellera Biologics — The Antibody Engine Nobody Is Talking About Most biotech investors chase companies with one shot at a blockbuster drug. AbCellera is building something different — a platform that discovers, develops, and manufactures antibody medicines across multiple disease areas simultaneously. And 2026 is shaping up to be the most important year in the company’s history. What They’ve Built AbCellera started as a drug discovery platform — helping partners like AbbVie find antibody candidates faster using AI, microfluidics, and single-cell screening. That partnership engine now has 104 cumulative program starts with downstream economics. 19 molecules have reached the clinic — up from just 14 two years ago. But the company has quietly made a major pivot: from platform partner to clinical-stage biotech with its own pipeline of first-in-class medicines. The Pipeline — Where It Gets Interesting ABCL635 — Women’s Health / Menopause → Potential first-in-class non-hormonal treatment for hot flashes (vasomotor symptoms) → Targets NK3R — a clinically validated receptor on neurons that regulate body temperature → Phase 1 safety data showed encouraging results + strong target engagement → fast-tracked into Phase 2 → Phase 2 is a randomized, double-blind, placebo-controlled study in 80 postmenopausal women → Top-line results from both Phase 1 and Phase 2 expected Q3 2026 This is a massive addressable market. ~30% of menopausal women experience moderate-to-severe symptoms. Most existing non-hormonal options have significant side effect profiles. A long-acting antibody approach could be a genuine category creator. ABCL575 — Immunology / Atopic Dermatitis → Phase 1 underway for moderate-to-severe atopic dermatitis → Targets OX40L — a regulator of inflammatory pathways → Engineered for every-6-month dosing convenience → Potential expansion into broader autoimmune conditions ABCL688 + ABCL386 — Both advancing into IND/CTA-enabling studies. 20+ programs in discovery. 1–3 new INDs per year planned going forward. Financial Foundation → FY2025 revenue: $75.1M (vs. $28.8M in FY2024 — massive jump) → Net loss narrowing: $146.4M in 2025 vs. $162.9M in 2024 → ~$500M plus in available liquidity — runway well beyond 3 years → Clinical manufacturing facility now operational The cash position is the key. AbCellera isn’t going to be diluted into oblivion chasing its pipeline. They have the runway to let the science play out. Why 2026 Is the Inflection Year The company entered 2025 as a platform business. It enters 2026 as a clinical-stage biotech with: → Two programs in active clinical trials → Top-line data from both expected this year → Two more candidates moving toward the clinic → A fully built manufacturing platform Q3 2026 ABCL635 readout is the single biggest near-term catalyst. Positive data in a large, underserved women’s health market could reprice this stock significantly. The Honest Risks → Still burning ~$150M/year — profitability is years away → Clinical-stage biotech = binary data risk (Phase 2 can fail) → Partnering revenue is lumpy and hard to model (Q4 2025 was inflated by a one-time patent settlement) → Stock has been under significant pressure — down sharply from its 2021 peak This is not a safe, steady compounder. It’s a high-conviction bet on the science. The Bigger Picture AbCellera has spent years and hundreds of millions building an antibody discovery and development engine that most companies can only dream of. The platform is complete. The clinical manufacturing facility is live. The pipeline is moving. Now they have to deliver data. If ABCL635 works — non-hormonal, long-acting, antibody-based relief for millions of women — this company looks very different by 2027. Watching closely.

@investmentguru_Apr 18, 2026 · 2:16 PM

20 Small Cap Stocks Across 20 Sectors — A 5-Year Framework $CIFR — AI Data Centers $BKSY — Space AI / Earth Intelligence $SOUN — Voice AI $RXRX — AI Drug Discovery $POET — Photonics $QS — Solid state battery $BTBT — Crypto + AI Infrastructure $SATL — Sovereign Satellites $SPIR — Space Data $KULR — Energy Storage $SERV — Delivery Robotics $ZETA — AI powered marketing $EVER — Insurtech $PATH — Enterprise automation $ABCL — AI drug discovery $GFAI — AI Security Robotics $ONDS — Defense Autonomy $AEYE — Accessibility SaaS $ADUR — Clean Tech $INFQ — Quantum Computing I will share short description and my favourite from this list later.

@investmentguru_Apr 17, 2026 · 1:22 AM

$ABCL $RXRX $PRME all 3 are still my favourite

@investmentguru_Apr 14, 2026 · 10:21 AM

25 Growth Stocks Poised to Be Big Winners - $IREN – AI infrastructure backbone $IONQ – quantum computing leader $RKLB – next-gen aerospace launch $ASTS – space-based connectivity $NBIS – emerging NeoCloud play $SOFI – fintech disruptor $EOSE – long-duration energy storage $ONDS – wireless + drone networks $QS – solid-state EV battery innovator $OKLO – small modular nuclear energy $HIMS – digital health platform $OSCR – tech-first insurance model $ZETA – AI-driven marketing data $ADUR – chemical recycling tech $AAOI – photonics infrastructure $CLPT – neuroscience breakthrough $PATH – enterprise automation + AI $JOBY – electric air mobility pioneer $MP – critical rare-earth supply chain $KTOS – autonomous defense $RR – robotics + automation $ABCL – AI-powered drug discovery $GLXY – digital asset + fintech $TE – solar + battery ecosystem $SOUN – voice AI platform Theme is clear: AI • Energy • Aerospace • Automation • Infrastructure Capital is rotating into the future — and these are the companies building it. Stay early. Stay positioned.

@investmentguru_Apr 3, 2026 · 12:27 PM

Portfolio performance $PLTR+795.24% $CLS +431.43% $ONDS+394.85% $NBIS+185.58% $HIMS+150.20% $SOFI+133.97% $RKLB+131.73% $OKLO+106.83% $TSLA+59.87% $IONQ+53.93% $NVDA+49.29% $RDW+32.74% $PNG+29.97% $QS +28.10% $ABCL+23.51% $AAOI+20.09% $META+17.37% $AMZN+16.59% $MU +3.48% $PATH+0.90% $GLXY-13.81%🩸 $RR -19.79%🩸 $JOBY-20.36%🩸 Cash: 3.87% Last add $AAOI 20% up and $MU 3.48 % up Not financial advice — just sharing the journey.

@investmentguru_Apr 1, 2026 · 10:51 AM

High Risk / High Reward Stocks Under $5 $RR → Robotics $PLUG → Clean Energy (Hydrogen) $INDI → Semiconductors (Auto AI) $SIVEF → Photonics / 5G $VLN → Semiconductors $SIDU → Space Technology $LASE → Photonics / Industrials $ZENA → Drones & Defense AI $BITF → AI infrastructure $OPEN → 🏠PropTech / Real Estate T $BULL → Financial Services / Fintech $EOSE → Energy Storage $MVST → EV Batteries / 🔋 storage $DFLI → Energy Storage (Solid-State) $ABCL → Biotech (Antibody Discovey $PRME → Biotech (Gene Editing) $TE → Energy solar $BTQ → Quantum Computing $EVTL → eVTOL / Electric Aviation $RXRX → AI Drug Discovery / Biotech $GRAB → Super App / Fintech $BBAI → Defense AI $BTG → Gold Mining $DGXX → AI Infrastructure $BCYC → 🧬 Biotech Not financial advice. DYOR.

@investmentguru_Mar 28, 2026 · 1:08 PM

One Stock, One Sector Leader: The Names Driving the Future. $NVDA — The backbone of the AI revolution. If AI runs on anything, it runs on Nvidia silicon. Data centers worldwide are still capacity-constrained. The demand cycle is far from over. $PLTR — Enterprise AI before enterprise AI was cool. Government + commercial contracts compounding. Palantir is quietly becoming the operating system for institutional decision-making. $ZETA — AI-native marketing tech flying under the radar. As ad budgets shift toward performance and personalization, Zeta’s data platform is positioned to capture serious share. $PATH — Automation at the enterprise level. UiPath’s agentic AI pivot could re-accelerate a story the market has been sleeping on. $GOOG — Cloud + Gemini + Search + YouTube. Still one of the best AI infrastructure plays hiding in plain sight. $META — The social layer of AI. Llama, Ray-Bans, Threads, Instagram — Meta is building the consumer-facing AI stack at massive scale. $SOFI — The fintech that kept executing while everyone wrote it off. Growing deposit base, product expansion, and profitability inflection make this one of the most compelling digital bank stories. $UBER — Platform economics + autonomous tailwinds. Waymo partnership alone could be a $10B+ opportunity over the next decade. $RKLB — Rocket Lab is becoming the SpaceX of small-launch. Neutron rocket development + satellite manufacturing = serious long-term upside. $ASTS — Direct-to-device satellite connectivity. If this works, it rewrites global telecom. The risk is real — so is the reward. $ONDS — Ondas is quietly building out drone and rail automation for defense + critical infrastructure. Under-the-radar with asymmetric potential. $JOBY — eVTOL is still pre-revenue, but Joby has the best shot at commercializing urban air mobility. FAA certification progress is the catalyst to watch. $OKLO — Nuclear is back. Oklo’s compact reactor model has Sam Altman-backed momentum and serious long-term energy infrastructure tailwinds. $QS — Solid-state batteries could transform EVs. QuantumScape is years from scale, but if they crack it, the upside is generational. $ABCL — AI-designed drugs. AbCellera’s platform approach to antibody discovery is early — but biotech + AI convergence is one of the biggest long-term themes. $HIMS — Digital health with a brand. Hims & Hers is compounding revenue, expanding into GLP-1s, and capturing the direct-to-consumer health shift. $IONQ — Quantum computing is 5–10 years from prime time, but IonQ is the purest public play. High risk, high optionality. $IREN — AI data infrastructure play. As compute demand explodes, companies enabling hyperscaler buildout become critical picks-and-shovels names. $KRKNF — Marine robotics is the defense + logistics frontier most investors haven’t found yet. Karman + autonomous underwater vehicles = early mover advantage. $AAOI — Optical networking is the quiet hero of AI infrastructure. Applied Optoelectronics is riding the data center connectivity wave. $TSLA — EV + Robotaxi + Optimus. Love it or hate it, Tesla remains the most ambitious hardware + AI company in the world. This are 21 names I’m watching — each one a sector leader positioned at the bleeding edge of where the world is going: Not financial advice. DYOR.

@investmentguru_Mar 20, 2026 · 10:51 AM

Where to concentrate in this market NeoCloud $IREN $CIFR $NBIS Photonics $COHR $LITE $POET $LWLG Chips $NVDA $MU $TSEM Drone + Defence $ONDS $KTOS $RCAT Robotics +Automation $SERV $TSLA $ISRG $PATH Fintech $SOFI $HOOD $GLXY Healthcare + Biotech $HIMS $VKTX $LLY $ABCL AI Infrastructure $PLTR $AMD $GLW $CLS Aerospace $RKLB $ASTS $PL $RDW Energy + renewables $OKLO $VRT $ENPH $TE Quantum $IONQ $RGTI $QUBT

@investmentguru_Mar 19, 2026 · 10:44 AM

Volatility Is Noise. Positioning Is Power. High-Conviction Growth Watchlist $NVDA — AI Chips / Infrastructure $PLTR — AI Software / Analytics $ZETA — AI Marketing Tech $PATH — Automation / Robotics $GOOG — Cloud / AI $AMZN — Cloud / E-commerce $META — AI / Platforms $CRWD — Cybersecurity $SOFI — Digital Banking $UBER — Mobility / Platform $RKLB — Space / Aerospace $ASTS — Space Connectivity $ONDS — Drones / Defense $JOBY — eVTOL / Air Mobility $ACHR — eVTOL / Aviation $ENPH — Solar $EOSE — Energy Storage $OKLO — Nuclear Energy $QS — Solid-State Batteries $UAMY — Critical Minerals $TE — Solar / Energy $ABCL — AI Drug Discovery $HIMS — Digital Health $IONQ — Quantum Computing $IREN — AI / Data Infrastructure $CIFR — Bitcoin Mining / HPC $KRKNF — Marine Robotics $AAOI — Optical Networking $LITE — Optical Components $POET — Photonics $TSLA - EV / robotic •Not all names will recover equally •Some will lead, some will lag •Risk management still matters Not financial advice.

@investmentguru_Mar 15, 2026 · 2:36 PM

25‑stock list — one leader from each major sector/theme to watch for future growth $IREN – AI infrastructure $IONQ – quantum computing $RKLB – aerospace launch $ASTS – aerospace connectivity $NBIS – NeoCloud $SOFI – Fintech $EOSE – energy storage $ONDS – wireless and drone networks. $QS – Solid-state EV battery disruptor. $OKLO – nuclear energy SMR $HIMS – digital health platform. $OSCR – Tech-first health insurance $ZETA – AI-marketing data platform. $ADUR – chemical recycling tech $POET – photonics $CLPT – neuroscience healthcare $PATH – Enterprise automation and AI $JOBY – Electric air taxi pioneer. $MP – Critical rare-earth supply $KTOS – Autonomous defense $RR – Robotics automation play. $ABCL – AI antibody discovery engine. $GLXY – digital Fintech $TE – solar and battery $SOUN – Voice AI platform

@investmentguru_Mar 15, 2026 · 12:49 PM

3 Other Biotech Companies on My Radar: $ABCL, $RXRX, $PRME Biotech is entering an explosive era of precision medicine, AI-driven discovery, and gene editing. While I track peptide and GLP-1 plays, here are 3 additional high-potential biotech names I’m watching closely: $ABCL Focus: AI-driven antibody discovery •Platform screens millions of immune cells to identify therapeutic antibodies quickly •Partnerships with Eli Lilly, Pfizer, Gilead, Novartis •Lead contributions: COVID-19 antibody therapy (bamlanivimab) •Market: Antibody therapeutics projected >$300B by 2030 Why watch: Recurring revenue from partnerships + royalties makes this a platform company with long-term upside $RXRX – Recursion Pharmaceuticals Focus: AI + high-throughput biology for drug discovery •Screens millions of compounds and genetic perturbations in human cells •Targeting rare genetic diseases and oncology •Platform enables faster, cheaper drug discovery Why watch: High-risk, high-reward play; the platform can produce multiple drug candidates simultaneously $PRME – Prime Medicine Focus: Prime editing gene therapy •Advanced CRISPR technology to rewrite DNA precisely •Targets rare genetic diseases and hematologic disorders •Platform could tackle thousands of monogenic disorders Why watch: Preclinical but huge potential; gene editing market expected to surpass $20B by 2030 •These three companies represent three high-growth biotech trends: 1.AI-powered discovery ($ABCL & $RXRX) 2.Gene editing & precision therapies ($PRME) •All are high-risk, high-reward plays with binary catalysts: trial readouts, partnerships, and platform validation Not a financial advice

@investmentguru_Mar 7, 2026 · 3:38 PM

From AI to Space to Clean Energy — 25 Stocks You Need on Your Radar $NVDA – AI Hardware $PLTR – AI Software $AMZN – Cloud / E-commerce $META – Social Media $CRWD – Cybersecurity $SOFI – Fintech $IONQ – Quantum Computing $OKLO – Nuclear Energy $NBIS – NeoCloud $IREN – AI Infrastructure $RKLB – Aerospace Launch $ASTS – Space Connectivity $TSLA – EV / Robotics $ZETA – AI Marketing $HIMS – Digital Health $PATH – Enterprise Automation $ONDS – Drones / Defense $QS – Solid-State Battery $JOBY – Electric Air Taxi $KTOS – Autonomous Defense $MP – Rare Earth Minerals $EOSE – Energy Storage $ABCL – AI Drug Discovery $SOUN – Voice AI $GOOG – Cloud / Internet These 25 stocks represent the building blocks of tomorrow’s economy — one pick per sector, each chosen for its disruptive potential, leadership position, and long-term growth runway. From the AI infrastructure powering the next computing era, to quantum computing unlocking problems we can’t yet solve, to clean energy reshaping how the world is powered, to space tech redefining connectivity — this isn’t a list of trends, it’s a map of where the world is going. The biggest winners of the next decade won’t be found in yesterday’s playbook. They’ll be found here, in the companies bold enough to build what doesn’t exist yet. Do your own research, size your positions wisely, and think in years — not weeks. Not financial advice. Always DYOR.

@investmentguru_Mar 7, 2026 · 3:20 PM

Portfolio Update 🟢 WINNERS $PLTR +844.32% $HIMS +187.58% $SOFI +173.97% $OKLO +150.19% $RKLB +138.22% $NBIS +134.14% $IONQ +86.69% $TSLA +74.99% $ONDS +407.73% $CLS +349.75% $NVDA +49.89% $ABCL +22.63% $META +31.13% $QS +36.23% $PNG +29.81% $AMZN +18.26% $RDW +17.67% 🔴 IN PROGRESS $GLXY -13.63% $PATH -23.81% $JOBY -21.61% $RR -34.84% 17/21 positions green Cash on hand: 8.7% of portfolio Not financial advice — just sharing the journey 📈

@stocksavvyshayFeb 20, 2026 · 2:53 PM

THE SUPER BOWL OF EARNINGS IS NEXT WEEK • Monday | $HIMS, $WGS, $BWXT, $KTOS • Tuesday | $MELI, $TEM, $AXON, $CIFR, $DOCN, $WDAY, $ZETA, $FSLR, $TMDX, $CAVA, $ABCL, $PRCT, $NVTS • Wednesday | $NVDA, $SNOW, $CRM, $IONQ, $NU, $TTD, $JOBY, $RDW, $PSTG, $ENVX, $CRCL, $ZM • Thursday | $RKLB, $EOSE, $CRWV, $DUOL $CELH, $QBTS, $ZS, $UUUU, $CPNG, $ESTC, $FOUR, $XYZ, $MP

@investmentguru_Feb 19, 2026 · 3:29 AM

Volatility Is Noise. Positioning Is Power My favourite 20 $PLTR $SOFI $RKLB $ASTS $ENPH $PATH $ZETA $SNAP $ABCL $KRKNF $UAMY $ONDS $EOSE $HYFT $JOBY $ACHR $TE $IREN $CIFR $UBER So many great stocks. So little capital. The key isn’t chasing what’s up. It’s building exposure to secular trends and adding on pullbacks. not a financial advise

@moninvestorFeb 18, 2026 · 6:00 PM

So many great stocks, so little capital. 🧐 If I were building my own ETF: $IREN $ONDS $CIFR $NBIS $WULF $IBRX $PL $ASTS $RKLB $NUAI $POET $ALMU $KRKNF $UAMY $COPX $OUST $TE $ENPH $OSS $SNAP $HIMS (depends on earnings) $PATH $ZETA $EOSE $JOBY $ACHR $LAES $ABCL $PRME $HYFT Top 30 > not in order.

@investmentguru_Feb 10, 2026 · 1:55 AM

These are growth stocks that could offer strong long-term opportunities. $IREN – AI infrastructure $IONQ – quantum computing $RKLB – aerospace launch $ASTS – aerospace connectivity $NBIS – NeoCloud $SOFI – Fintech $EOSE – energy storage $ONDS – wireless and drone networks. $QS – Solid-state EV battery disruptor. $OKLO – nuclear energy SMR $HIMS – digital health platform. $OSCR – Tech-first health insurance $ZETA – AI-marketing data platform. $ADUR – chemical recycling tech $CLPT – neuroscience healthcare $PATH – Enterprise automation and AI $JOBY – Electric air taxi pioneer. $MP – Critical rare-earth supply $KTOS – Autonomous defense $RR – Robotics automation play. $ABCL – AI antibody discovery engine. $GLXY – digital Fintech $TE – solar and battery $SOUN – Voice AI platform

@investmentguru_Feb 1, 2026 · 2:43 PM

Where I’m Placing My Bets for 2026 $RKLB — Aerospace: The future of space launches is here $IONQ — Quantum Computing: Leading the quantum revolution $IREN — AI Infrastructure: Powering next-gen AI systems $NBIS — NeoCloud: Cloud solutions with a new edge $SOFI — Fintech: Transforming personal finance $ONDS — Drone Tech: Drones are the next big thing in logistics & defense $QS — Battery Tech: Energy storage for a sustainable future $EOSE — Energy Storage: Building the backbone of green energy $OKLO — Nuclear Energy: Small modular reactors, big potential $JOBY — eVTOL: The dawn of urban air mobility $RR — Robotics: Industrial automation at scale $PATH — AI Automation: Making AI work smarter for businesses $ABCL — Biotech: Innovative therapies in the healthcare frontier $HIMS — Healthcare: Telehealth and wellness solutions growing fast $ZETA — AI Marketing: Driving next-gen digital marketing with AI

@investmentguru_Jan 30, 2026 · 11:47 AM

Positioning Early: Growth Stocks That May Lead the Market in 2026 $IREN – AI infrastructure $IONQ – quantum computing $RKLB – aerospace launch $ASTS – aerospace connectivity $NBIS – NeoCloud $SOFI – Fintech $EOSE – energy storage $ONDS – wireless and drone networks. $QS – Solid-state EV battery disruptor. $OKLO – nuclear energy SMR $HIMS – digital Healthcare. $OSCR – Tech-first health insurance $ZETA – AI-marketing data platform. $ADUR – chemical recycling tech $AMPX – battery play $CLPT – neuroscience healthcare $PATH – Enterprise automation and AI $JOBY – Electric air taxi pioneer. $MP – Critical rare-earth supply $KTOS – Autonomous defense $RR – Robotics automation play. $ABCL – AI antibody discovery engine. $GLXY – digital Fintech $TE – solar and battery $SOUN – Voice AI platform Not a financial advice

@investmentguru_Jan 25, 2026 · 3:36 PM

Top 10 Biotech Stocks to Watch in 2026 $PRME – Prime Medicine Precision genetic medicine with deep science and long-term pipeline potential. $RXRX – Recursion Pharmaceuticals AI-driven drug discovery platform accelerating therapeutic development. $ABCL – AbCellera Biologics Antibody discovery partner with big pharma programs and diversified pipeline. $KROS – Keros Therapeutics Small-cap biotech showing massive year-over-year revenue growth and rapid expansion in its pipeline. $GERN – Geron Gene-targeting therapeutics with huge reported revenue growth metrics. $SGMO – Sangamo Therapeutics Cell and gene therapy company with notable growth in recent quarters. $LXRX – Lexicon Pharmaceuticals Clinical-stage biotech with strong growth and a diversified asset base. $MGTX – MeiraGTx Gene therapy developer with increasing pipeline and research expansion. $EDIT – Editas Medicine Gene editing biotech driving next-gen therapies with robust growth numbers. $ENSC – Ensysce Biosciences Ultra-small cap with huge revenue expansion — moonshot potential but high risk.

@investmentguru_Jan 24, 2026 · 4:18 PM

The goal isn’t just chasing returns—it’s about strategically positioning for the next wave of innovation and growth. $TSLA entry $225.55 $NVDA entry $131.18 $AMZN entry $179.70 $GOOG entry $153.18 $LLY entry $586.33 $CLS entry $55.84 $META entry $489.14 $PLTR entry $16.58 $IONQ entry $8.15 $OKLO entry $18.70 $HIMS entry $7.65 $SOFI entry $6.77 $ENVX entry $8.76 $RKLB entry $25.57 $IREN entry $10.88 $NU entry $10.52 $QS entry $5.23 $ABCL entry $2.85 $BLNK entry $1.70 $QBTS entry $6.68

@investmentguru_Jan 22, 2026 · 4:00 PM

Biotech looking good $MRNA $PRME $ABCL $RXRX

@investmentguru_Jan 20, 2026 · 1:07 AM

25 Stocks That Could Be Strong Adds if the Market Sees a Bigger Pullback AI, Compute & Next-Gen Infrastructure $IREN – AI-driven data center and compute infrastructure tied to long-term demand growth $IONQ – Pure-play quantum computing with real enterprise and government traction $NBIS – Emerging NeoCloud platform targeting specialized AI workloads $ZETA – AI-powered marketing and data intelligence platform $PATH – Enterprise automation blending AI with mission-critical workflows $SOUN – Voice AI platform gaining adoption across auto and enterprise Aerospace, Defense & Robotics $RKLB – End-to-end space launch and satellite systems provider $ASTS – Direct-to-device satellite connectivity with massive global potential $JOBY – Electric air taxi pioneer pushing toward commercial deployment $KTOS – Autonomous defense systems aligned with modern warfare trends $RR – Robotics automation play benefiting from labor and efficiency shifts Energy, Storage & Critical Resources $OKLO – Small modular nuclear reactors for next-gen energy needs $EOSE – Long-duration energy storage for grid stability $QS – Solid-state battery disruptor targeting EV and storage markets $MP – Critical rare-earth supply essential for EVs, defense, and clean energy $TE – Solar and battery solutions supporting the energy transition Healthcare, Biotech & Digital Health $HIMS – Scalable digital health platform with strong consumer engagement $OSCR – Tech-first health insurance reshaping legacy models $ABCL – AI-driven antibody discovery engine with platform potential $CLPT – Neuroscience-focused healthcare with differentiated IP Fintech, Digital Assets & Networks $SOFI – Full-stack fintech ecosystem positioned for rate-cycle shifts $GLXY – Digital-asset-focused financial services and infrastructure $ONDS – Wireless and drone network solutions for defense and enterprise Market pullbacks don’t destroy long-term opportunities — they usually reprice them. Volatility is the price paid for long-term outperformance. Not a financial advise

@investmentguru_Jan 18, 2026 · 12:47 PM

2026 Focus: Plays Aerospace & Defense $KTOS • $RKLB • $ASTS • $RDW Energy (Renewables, Storage, Nuclear) $FSLR • $ENPH • $OKLO • $EOSE • $TE Critical Minerals & rare earth $LAC • $MP • $CRML • $TMC • $IDR • $UAMY AI Infrastructure / NeoCloud $NVDA • $AMD • $NBIS • $IREN • $PLTR Semiconductors & Manufacturing $TSM • $ASML • $INTC • $AMAT • $LRCX Healthcare & Biotechnology $LLY • $ABCL • $HIMS • $RXRX Robotics & Automation $TSLA • $ISRG • $SYM • $RR • $PATH Power Infrastructure $EQIX • $VRT • $ETN • $CEG • $BE • $GEV Crypto & Blockchain $COIN • $MSTR • $GLXY • $BMNR • $CLSK Drones & eVTOL $JOBY • $ACHR • $ONDS

@investmentguru_Jan 17, 2026 · 11:02 PM

25 Growth Stocks Poised to Be Big Winners $IREN – AI infrastructure $IONQ – quantum computing $RKLB – aerospace launch $ASTS – aerospace connectivity $NBIS – NeoCloud $SOFI – Fintech $EOSE – energy storage $ONDS – wireless and drone networks. $QS – Solid-state EV battery disruptor. $OKLO – nuclear energy SMR $HIMS – digital health platform. $OSCR – Tech-first health insurance $ZETA – AI-marketing data platform. $ADUR – chemical recycling tech $SKYT – semiconductor $CLPT – neuroscience healthcare $PATH – Enterprise automation and AI $JOBY – Electric air taxi pioneer. $MP – Critical rare-earth supply $KTOS – Autonomous defense $RR – Robotics automation play. $ABCL – AI antibody discovery engine. $GLXY – digital Fintech $TE – solar and battery $SOUN – Voice AI platform

@investmentguru_Jan 17, 2026 · 2:40 PM

Portfolio Performance as of Jan 16, $PLTR +934.90% $ONDS +534.54% $CLS +464.04% $HIMS +312.94% $OKLO +309.02% $SOFI +285.27% $RKLB +229.68% $NBIS +186.06% $IONQ +165.84% $QS +114.92% $TSLA +93.92% $NVDA +56.81% $RDW +63.70% $GLXY +45.13% $ABCL +47.68% $AMZN +32.90% $META +26.89% $PNG +24.38% $JOBY +11.39% $RR +7.40% $PATH −7.79% 🔻

@midascabalJan 14, 2026 · 10:09 PM

Like if $ABCL is going to explode after the JPM presentation today.

@investmentguru_Jan 14, 2026 · 1:54 AM

Key themes to watch: •Early Detection ( $GH, $EXAS ) : AI-driven diagnostics and liquid biopsy remain one of the fastest paths to real-world impact and revenue scalability. •Robotics & Automation ( $ISRG, $RBOT ) : Surgical automation is a long-duration growth story as hospitals push for precision, efficiency, and cost control. •Multi-omics & Genomics ( $TXG, $ILMN, $CRSP, $BEAM $TEM ) : AI + sequencing is accelerating target discovery, personalization, and next-gen therapies. •Virtual Care & Monitoring ( $TDOC, $HIMS ) : AI-driven engagement, triage, and personalization continue to reshape patient access and care delivery. •AI Drug Discovery ( $RXRX, $SDGR, $ABCL ) : Platform-based models remain volatile short term but offer asymmetric upside as pipelines mature. •Infrastructure & Enablers ( $VEEV, $DOCS, $GEHC ) : The “picks and shovels” of AI healthcare adoption.

@midascabalJan 13, 2026 · 2:48 PM

Like if $ABCL is going to the moon this week.

@midascabalJan 12, 2026 · 9:58 PM

Like if $ABCL is going to explode this week.

@investmentguru_Jan 12, 2026 · 6:32 PM

$ABCL https://t.co/alUEfO7QmK

@investmentguru_Jan 11, 2026 · 3:21 PM

One Stock from Each Sector I’m Watching for 2026 •Aerospace: $RKLB – The future of space launches is here. •Quantum Computing: $IONQ – Leading the quantum revolution. •AI Infrastructure: $IREN – Powering next-gen AI systems. •NeoCloud: $NBIS – Cloud solutions with a new edge. •Fintech: $SOFI – Transforming personal finance. •Drone Tech: $ONDS – Drones are the next big thing in logistics & defense. •Battery Tech: $QS – Energy storage for a sustainable future. •Energy Storage: $EOSE – Building the backbone of green energy. •Nuclear Energy: $OKLO – Small modular reactors, big potential. •eVTOL: $JOBY – The dawn of urban air mobility. •Robotics: $RR – Industrial automation at scale. •AI Automation: $PATH – Making AI work smarter for businesses. •Biotech: $ABCL – Innovative therapies in the healthcare frontier. •Healthcare: $HIMS – Telehealth and wellness solutions growing fast. •AI Marketing: $ZETA – Driving next-gen digital marketing with AI.

@investmentguru_Jan 10, 2026 · 2:23 PM

5 Core Sectors Your Portfolio Should Be Focused On for 2026. The next market cycle will be driven by power, compute, connectivity, health, and automation. Positioning early across these themes is how long-term outperformance is built. 1) Energy / Nuclear / Renewables Power is the new bottleneck. AI, electrification, and reshoring demand reliable, scalable energy. $OKLO $EOSE $LEU $ENPH $FSLR $QS $CCJ $SMR $BWXT $ETN 2) AI & Data Centers The backbone of large-scale model training, inference, and automation. $NBIS $IREN $CIFR $ZETA $VRT $AVGO $MRVL $AMD $NVDA 3) Aerospace Building global connectivity, launch capability, and orbital infrastructure. $ASTS $RKLB $PL $RDW $KTOS $LMT $BA $ONDS 4) Healthcare Tech-enabled healthcare, data-driven treatment, and consumer-first models. $OSCR $UNH $NVO $HIMS $LLY $ABCL $ISRG 5) Robotics & Automation AI-driven machines transforming transport, factories, and defense. $TSLA $RR $PATH $SYM $TER $KTOS $SOUN This is where capital, policy, and innovation are converging into 2026 and beyond. The strongest portfolios will be built around these pillars. NOT A FINANCIAL ADVICE

@investmentguru_Jan 9, 2026 · 1:32 AM

$ABCL one of my high conviction stock.

@investmentguru_Jan 8, 2026 · 12:01 PM

Healthcare stocks could attract buying interest, presenting potential opportunities for both growth and defensive plays. $NVO $HIMS $ABCL $RXRX $PRME $UNH $OSCR

@investmentguru_Jan 7, 2026 · 7:58 PM

$ABCL $RXRX $PRME Value buying

@investmentguru_Jan 7, 2026 · 11:37 AM

$ABCL $RXRX $PRME

@investmentguru_Jan 7, 2026 · 11:37 AM

$ABCL $RXRX $PRME Buying opportunity for long term.

@investmentguru_Jan 7, 2026 · 1:18 AM

Some Big Green Stocks today $SIDU $SKYT $AXTI $RKLB $ASTS $OKLO $ZETA $PATH $OPEN $NVTS $CRML $ABCL $TSSI

@investmentguru_Jan 5, 2026 · 11:52 AM

$ABCL $PRME $RXRX Best possible buying opportunity for LONG TERM, IMO

@moninvestorJan 4, 2026 · 1:14 PM

This was my portfolio going into 2024. Four companies from that list have gone on to become giant companies today. In two years: $SOFI +248% $HIMS +300% $PLTR +950% $RKLB +1,307% Around May 2024, I decided to concentrate my portfolio into HIMS. I then added IREN around mid-year. Going into 2025, my portfolio consisted of just two stocks, IREN and HIMS, roughly 50% each. Later, when HIMS reached my price target for the second time, I took a significant amount of profit and added a new long-term positions. I also created a short-term portfolio around August. That meant a lot of work to achieve the returns I had in 2025. Looking back, I didn’t need to do any of it. If I had simply held those four stocks, I think I would have been fine and likely ended up with a similar return. Other positions over the past 2 years: $MTTR got acquired. $ENPH -53% $ABCL -41% $ABNB -2% My conviction was only really strong in Enphase. Looking back, I ended up selling all of them within a few months.

@investmentguru_Jan 4, 2026 · 1:13 PM

Big Picture | Where the Next Cycle Is Taking Us: Space: The Next Strategic Infrastructure Layer $RKLB, $ASTS, $RDW, $PL Enterprise AI: From Pilots to Profits $PLTR, $SNOW, $NOW Mag 7: Leadership Rotation, Not Extinction $NVDA, $GOOGL, $MSFT, $META, $AAPL, $TSLA, $AMZN Power & Energy: The Real AI Bottleneck $CEG, $EOSE, $OKLO Semiconductors: The Picks-and-Shovels of Every Megatrend $NVDA, $AMD, $AVGO, $ARM Defense & Autonomy: Geopolitics Meets AI $KTOS, $LMT, $RTX, $PLTR, $ONDS Robotics & Automation: Solving the Labor Shortage $TSLA, $SYM, $ISRG, $ABB, $RR AI Infrastructure & Data Centers $NBIS $CIFR $IREN Fintech 2.0: Profitable, Scaled, Embedded $SOFI, $HOOD, $PYPL Healthcare AI & Biotech Platforms $ABCL, $RXRX, $VKTX Uranium & Nuclear Renaissance $OKLO, $SMR, $CCJ, $LEU Battery Tech & Energy Storage $QS, $ENVX, $EOSE, $FLNC, $BE

@investmentguru_Jan 4, 2026 · 12:26 PM

Portfolio performance: This is what conviction + patience + holding through noise looks like. $PLTR → +923.02% $ONDS → +469.07% $CLS → +446.14% $HIMS → +337.65% $SOFI → +306.08% $OKLO → +236.01% $RKLB → +160.34% $IONQ → +145.49% $NBIS → +137.26% $QS → +126.51% $TSLA → +95.74% $NVDA → +59.11% $META → +32.86% $AMZN → +26.13% $RDW → +23.70% $ABCL → +18.95% $GLXY → +4.12% $PNG → +5.43% $JOBY → +3.13% $PATH → +2.64% $RR → −3.34% 🔻 $BULL → −29.73% 🔻🔻

@investmentguru_Dec 28, 2025 · 1:07 PM

Big Picture | Where the Next Cycle Is Taking Us: Space: $RKLB, $ASTS, $RDW, $PL Enterprise AI: $PLTR, $SNOW, $MDB, $NOW Mag 7: $NVDA, $GOOGL, $MSFT, $META, $AAPL, $TSLA, $AMZN Power & Energy: $CEG, $OKLO, $BE Semiconductors: $NVDA, $AMD, $AVGO, $ARM Defense & Autonomy: $KTOS, $LMT, $PLTR, $ONDS Robotics & Automation: $TSLA, $SYM, $ISRG, $ABB, $RR AI Infrastructure & Data Centers $NBIS $CIFR $IREN Fintech: $SOFI, $HOOD, $PYPL, $AFRM, Healthcare AI & Biotech Platforms $ABCL, $RXRX, $VKTX Uranium & Nuclear Renaissance $OKLO, $SMR, $BWXT, $LEU Battery Tech & Energy Storage $QS, $EOSE, $FLNC, $BE

@investmentguru_Dec 25, 2025 · 3:34 PM

@FloridaHokie20 $RXRX $ABCL and $PRME my 3 favourite biotech for 2026 💪

@investmentguru_Dec 21, 2025 · 12:27 PM

Preparing for 2026: 20 high risk high reward stocks to watch $RR — Robotics / Automation $EVTL — eVTOL / Electric Aviation $PLUG — Clean Energy / Hydrogen $FUBO — Streaming / Sports Media $BITF — Bitcoin / Digital Infrastructure $DGXX — Blockchain / Digital Assets $BB — Cybersecurity / IoT $NAK — Mining / Critical Metals $SLNH — Bitcoin/Energy Infrastructur $MVST — Energy Storage / Batteries $ASTI — Solar / aerospace $BYND — plant food / Food Tech $ASST — digital assets/ BTC $NXDR —social neighbours network $ABAT — Battery Recycling / EV $LAES — chips/ quantum $DFLI — EV battery $BTQ — Quantum Cybersecurity $RXRX — AI Drug Discovery / Biotech $ABCL — Biotech /Antibody Platforms

@moninvestorDec 20, 2025 · 3:21 PM

Forgot to add few other names, notably $NBIS, $SLNH & $ABCL.

@investmentguru_Dec 20, 2025 · 1:27 PM

Portfolio performance update- added $RDW , $JOBY and $RR to portfolio and now 21 positions. $PLTR +1069.79% $CLS +433.45% $ONDS +374.23% $HIMS +366.67% $SOFI +304.31% $OKLO +262.48% $IONQ +155.96% $RKLB +150.91% $NBIS +138.16% $QS +133.83% $TSLA +113.96% $NVDA +52.70% $META +35.31% $ABCL +27.75% $AMZN +26.81% $RDW +13.84% $PATH +3.99% $JOBY +2.49% $GLXY +2.30% $RR -1.16% $BULL -25.97% 🔻🔻🔻

@investmentguru_Dec 16, 2025 · 11:49 AM

High Risk / High Reward Watchlist: $BITF $RR $EVTL $POET $BBAI $ABCL $RXRX $RDW $FUBO $TE For high-risk, high-reward opportunities, this is the part of my watchlist where asymmetric upside matters most. These names carry volatility, but also the potential for outsized returns if execution and market conditions align.

@investmentguru_Dec 15, 2025 · 12:32 AM

Portfolio Update: Exited $BLNK and $OSCR. Now holding 18 positions with ~10% cash. Two new additions planned in the coming weeks—will update once added. $PLTR +998.39% $CLS +452.45% $HIMS +385.49% $ONDS +347.94% $SOFI +300.18% $OKLO +278.38% $IONQ +163.21% $QS +139.93% $NBIS +129.25% $RKLB +107.38% $TSLA +102.27% $NVDA +47.51% $META +31.57% $ABCL +27.02% $AMZN +25.87% $GLXY +12.45% $PATH +11.97% $BULL −22.05% 🔻🔻

@mrmikeinvestingJul 17, 2025 · 9:52 PM

I’ve created generational wealth by calling the bottoms on the following stocks… 1. $PLTR at $42 2. $NVDA at $85 3. $HOOD at $29 4. $AMD at $76 5. $HIMS at $22 My next picks to breakout are $ZETA, $OSCR, $LMND, $IREN, $ABCL, & $RKLB. Don’t miss my updates posted here on X… https://t.co/VWIB9lot9c